Skip to main content
OpenTrials
Completed

NCT Number: NCT03404921

Efficacy and Safety of Endoscopic Submucosal Tunnel Dissection for Superficial Esophageal Squamous Cell Carcinoma

To evaluate the efficacy and safety profile of endoscopic submucosal tunnel dissection for superficial esophageal squamous cell carcinoma.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Xijing Hospital of Digestive Diseases

Xi'an, Shaanxi, 710032, China

About this study

This multicenter, prospective, randomized, controlled study aims to evaluate the efficacy and safety of the tunnel technique in ESD of superficial esophageal squamous cell carcinoma (ESCC). Specifically the tunnel technique would be compared to conventional method on the procedure time and the muscular layer injury rate in patients scheduled for ESD with indication of ESCC.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ≥18 years;
  • Biopsy confirmed early esophageal cancer and high-grade intraepithelial neoplasia (HGIN)which were eligible for conventional ESD indications;
  • Suspected localized mucosal lesions detected by endoscopy.

Exclusion criteria

  • Malignancy or other advanced disease with a life expectancy of < 6 months as judged by the investigator.
  • The ASA classification of physical status ≥ 4 as judged by the investigator.
  • Severe hepatic disease or renal disease
  • Ability to understand and the willingness to sign a written informed consent document.
  • Major cardiovascular event at enrollment or within 3 months prior to enrollment such as stroke, myocardial infarction, or hospitalization for treatment of unstable angina pectoris as judged by the investigator.
  • Haemorrhagic disorder.
  • Patients who had a history of esophagectomy or a recurrent lesion.
  • Planned treatment with: warfarin (including other vitamin K antagonists), cisapride,phenytoin, atazanavir, nelfinavir, digoxin, methotrexate, clopidogrel, tacrolimus,theophylline, lidocaine, nifedipine.
  • Pregnancy, planned pregnancy or lactation. Women of childbearing potential must use reliable and medically accepted methods of birth control, as judged by the investigator.
  • Known or suspected alcohol, drug or medication abuse.
  • Any condition associated with poor compliance as judged by the investigator.
  • Participation in any study involving administration of an investigational product or device within the preceding 14 days prior to enrollment.
  • Involvement in the planning and conduct of the study. Previous enrollment in the present study

Treatment and study plan

ESTD

Procedure

During the ESTD procedure,after marking and submucosal injection, incisions were made at both the anal and oral sides of the lesion, and the submucosa under the lesion was then dissected to create a tunnel between the distal and proximal incisions. When the endscope reached the lower incision, the distal end of the esophageal lumen could be visualized , then two lateral mucosal incisions were made, thus completing the ESD procedure.

ESD

Procedure

The ESD procedure involved marking,injection,circumferential cutting, submucosal dissection.

Primary outcomes

  1. The procedure time

    Time frame: day 1

    Procedure time was defined as the time from marking of the lesion until complete removal of the specimen,including hemostasis.

Secondary outcomes

  1. The rate of bleeding during operation

    Time frame: day 1

    The hemorrhage observed during the operation

  2. The rate of injury to the muscular layer

    Time frame: day 1

    The injury to the muscular layer observed during the operation

Sponsors and collaborators

Lead sponsor

Xijing Hospital of Digestive Diseases

Other

Collaborators

  • First Affiliated Hospital Xi'an Jiaotong University
  • First Affiliated Hospital of Suzhou Medical College
  • Peking University Cancer Hospital & Institute
  • Shanghai Zhongshan Hospital
  • Tongji Hospital

Registry information

Official study title

Efficacy and Safety of Endoscopic Submucosal Tunnel Dissection for Superficial Esophageal Squamous Cell Carcinoma: a Prospective Multicenter Study

Important dates

Study start
2018
Primary completion
2018
Study completion
2018
First posted
Jan 19, 2018
Registry last updated
Jul 17, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.